SelectScience InterviewsLife Sciences
Privacy-preserving systems medicine for drug target discovery
26 Jun 2025
CoSy.Bio is at the forefront of systems biology research, focusing on advancing personalized medicine and drug repurposing. Here, Dr. Jan Baumbach shares how CoSy.Bio is transforming systems medicine through privacy-aware AI, enabling secure collaboration across institutions and borders while safeguarding patient privacy. Learn about key challenges in computational biology and how innovations like federated learning and distributed data analysis are addressing them.
This video was filmed at SLAS Europe 2025.
Tags
SLASThe Society for Laboratory Automation and Screening (SLAS) is an organization focused on laboratory automation, high-throughput screening, and biotechnology innovation. SLAS promotes scientific advancements through conferences, publications, and industry collaborations. Drug Discovery & Development ScreeningAutomationAutomation in laboratories and manufacturing processes enhances efficiency, precision, and scalability by reducing the need for manual intervention. It plays a critical role in improving productivity, minimizing human error, and accelerating workflows in fields like diagnostics, drug development, and industrial testing. Automation technologies include robotic systems, automated liquid handlers, and process control systems that streamline complex tasks and ensure consistent, reproducible results. Explore our peer-reviewed product directory to discover the best automation solutions, compare options, read user reviews, and get prices directly from manufacturers.AIPersonalized medicinePersonalized medicine refers to the idea of customized healthcare, where medical decisions and treatments are tailored to the individual patient. Molecular diagnostics, companion diagnostics and Next Generation Sequencing (NGS) play a pivotal role in this approach.BioinformaticsBioinformatics uses computational models and methodologies to study biological processes and to understand biological data.